Approval · Notice of Compliance 17427 · 2015
BYDUREON: Notice of Compliance 17427
Issued October 30, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17427
- Date
- October 30, 2015
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BYDUREON | 02448610 | Cancelled Post Market |
Medicinal ingredients
- EXENATIDE 2 MG per DOSE